Banner

Notice Home

NOTICE TO THE BAR

RE: MASS TORTS -- APPLICATION TO DESIGNATE LITIGATION INVOLVING THE DRUGS RISPERDAL, SEROQUEL AND ZYPREXA AS A MASS TORT

Pursuant to Rule 4:38A ("Centralized Management of Mass Torts") and Directive # 11-03 ("Mass Torts - Guidelines and Criteria for Designation"), an application has been made to the Supreme Court, through the Administrative Director of the Courts, to designate all litigation in the New Jersey state courts involving the drugs Risperdal, Seroquel and Zyprexa as a mass tort for centralized management in Middlesex County by Judge Bryan D. Garruto with the assistance of Special Master Agatha N. Dzikiewicz. A copy of the application is posted on the Judiciary's Internet Mass Tort Info Center at http://www.judiciary.state.nj.us/mass-tort/index.htm

Anyone wishing to comment on or object to this application should provide such comments or objections in writing, with relevant supporting documentation, to Hon. Philip S. Carchman, Acting Administrative Director of the Courts, Hughes Justice Complex, P. O. Box 037, Trenton, NJ 08625-0037, by August 1, 2006.

Philip S. Carchman, J.A.D.
Acting Administrative Director of the Courts
Dated: June 28, 2006

  Copyrighted © 2001 - New Jersey Judiciary